Facebook
Twitter
LinkedIn
Forward
Poor responders to common medical weight loss treatments is a challenging situation for clinicians.
|
This talk will review key features of obesity pathogenesis related to genetics, the brain, and energetics.
|
An important part of the Obesity Medicine provider’s practice, and one of the pillars of obesity care, is considering the use of medications for the treatment of overweight and obesity. Anti-obesi
|
CME/CE Expiration Date: 6/29/2026* *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.
|
Physical activity is often considered the “calorie-out” part of the equation of calorie balance.
|
Description:
|
Sarcopenic obesity presents numerous risks to health and quality of life.
|
This webinar re-playing the popular session from the Obesity Medicine Conference 2021 provides a brief overview of FDA-approved anti-obesity medications (AOM’s).
|
The global COVID-19 pandemic has turned our patient’s lives and routines upside down.
|
Patients and Primary Care Clinicians face numerous difficulties in providing effective, affordable weight loss and maintenance programs.
|